Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids

Margaret Ann Kreher, Mary Margaret B. Noland, Sailesh Konda, María Isabel Longo, Rodrigo Valdés‐Rodríguez

2022Journal of the American Academy of Dermatology56 citationsDOI

Topics & Concepts

MedicineCalcineurinSkin cancerPimecrolimusDiscovery and development of mTOR inhibitorsDermatologyMelanomaTacrolimusPharmacologyCancerOncologyPI3K/AKT/mTOR pathwayCancer researchInternal medicineTransplantationSignal transductionChemistryBiochemistryNonmelanoma Skin Cancer StudiesPolyomavirus and related diseasesCutaneous Melanoma Detection and Management